Showing results (31-40 of 76) with videos related to
Sort By:
Pageof 8
Pharmacological Research Communications|May 1, 1985
Opioid activity of lefetamineM G De Montis, P Devoto, A Bucarelli, et al.Pediatrie|January 1, 1991
[Maternal depression as a severity factor in respiratory hypersensitivity in children]G de Montis, M Chaussain, M Granoff, et al.Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|January 1, 1995
[Peanut sensitization and oily solution vitamin preparations]G de Montis, M Truong, B Toussaint, et al.Annales De Medecine Interne|January 1, 1990
[Rhesus phenotype and lymphocyte subpopulations]G de Montis, E Maheu, G Huchet, et al.Journal of Neurochemistry|August 4, 2004
Dopamine and cyclic AMP-regulated phosphoprotein-32 phosphorylation pattern in cocaine and morphine-sensitized ratsS Scheggi, R Rauggi, C Gambarana, et al.Neuroscience|June 30, 2009
Dopamine D1 receptor-dependent modifications in the dopamine and cAMP-regulated phosphoprotein of Mr 32 kDa phosphorylation pattern in striatal areas of morphine-sensitized ratsS Scheggi, A Crociani, M G De Montis, et al.Neurobiology of Aging|March 1, 1990
Failure of dark adaptation to upregulate D-1 dopamine receptors in retina of senescent ratsM L Porceddu, G De Montis, S Pepitoni, et al.Brain Research|March 19, 1993
Long-term imipramine effects are prevented by NMDA receptor blockadeM G De Montis, C Gambarana, D Meloni, et al.Brain Research|October 27, 1987
D1 dopamine receptors in the rat retina: effect of dark adaptation and chronic blockade by SCH 23390M L Porceddu, G De Montis, S Mele, et al.Brain Research. Brain Research Protocols|March 29, 2001
Animal models for the study of antidepressant activityC Gambarana, S Scheggi, A Tagliamonte, et al.Pageof 8